Q:

Is the viability of cells from diseased or diabetic donors less than cells from normal donors?

A:

We guarantee > 70 % viability for cells from both diseased/diabetic donors and normal donors.

Categories:
Primary Cells and Media
Research Areas:
Cancer Research/Cell Biology
Cardiovascular
Dermatology/Tissue Engineering
Gastroenterology
Immunotherapy / Hematology
Stem Cells
Basic Research
Toxicology

You may also want to know:

Generation of a stable cell line: A positive control plasmid works, but I cannot obtain stable clones with my construct of interest. What could be the reason?
How long does it take to obtain stable transfectants?
What selection markers can I use for the generation of stable cell lines?
Is your pmaxGFP control vector supplied with the Nucleofector® Kits suitable for stable expression?
How many stable clones will I get from one transfection?
Why is the Nucleofector® Technology ideal for protein production from stable clones ?
In stable cell line generation, I have a very high transfection efficiency, but most of my cells die during selection. Is this to be expected?
Following Nucleofection®, I cannot obtain stable clones from single cells. What could be the reason?
How long is the MycoAlert® Mycoplasma Detection Assay signal stable?
What antibiotic concentration should I use for selecting stable transfectants?
See More

Privacy | Legal | About Lonza

© Lonza. All rights reserved.